LICI.NS(LICI.NS)
LICI.NS
No analyst ratings available
No analyst price targets available for LICI.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $10.49T | $11.36T | $12.44T |
| Low | $10.25T | $10.90T | $11.32T |
| High | $10.83T | $12.00T | $13.01T |
| EBITDA Avg | $452.80B | $490.53B | $537.27B |
| Low | $442.59B | $470.82B | $488.67B |
| High | $467.88B | $518.37B | $561.85B |
| EBIT Avg | $447.96B | $485.28B | $531.52B |
| Low | $437.86B | $465.78B | $483.44B |
| High | $462.87B | $512.82B | $555.83B |
| Net Income Avg | $589.96B | $648.47B | $769.09B |
| Low | $570.05B | $601.61B | $678.09B |
| High | $651.82B | $757.24B | $860.10B |
| EPS Avg | $48.10 | $53.36 | $60.80 |
| Low | $45.07 | $47.56 | $53.61 |
| High | $51.53 | $59.86 | $68.00 |
| Analysts (Rev / EPS) | 7 / 8 | 8 / 8 | 1 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $1.37T | $1.35T | $1.80T |
| Low | $1.37T | $1.35T | $1.80T |
| High | $1.37T | $1.35T | $1.80T |
| EBITDA Avg | $59.24B | $58.39B | $77.76B |
| Low | $59.24B | $58.39B | $77.76B |
| High | $59.24B | $58.39B | $77.76B |
| EBIT Avg | $58.60B | $57.76B | $76.93B |
| Low | $58.60B | $57.76B | $76.93B |
| High | $58.60B | $57.76B | $76.93B |
| Net Income Avg | $193.18B | $248.33B | $-130.94B |
| Low | $193.18B | $248.33B | $-130.94B |
| High | $193.18B | $248.33B | $-130.94B |
| EPS Avg | $15.27 | $19.63 | $-10.35 |
| Low | $15.27 | $19.63 | $-10.35 |
| High | $15.27 | $19.63 | $-10.35 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |